go back

Wyoming rates for HCPCS Q2056

Ciltacabtagene autoleucel, up to 100 million autologous B-cell maturation antigen (BCMA) directed CAR-positive T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Facilitymedian $1,096,478 · 10th–90th $588,844–$1,230,2690%20%40%10th90th$1,096,478Professionalmedian $691,831 · 10th–90th $588,844–$691,8310%50%10th$691,831$1.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample — interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
Aetna
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66
BCBS
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $691,830.97 / $691,830.97
United
Facility/Professional
Facility
Modifier
Typical Low / Median / Typical High
$912,010.84 / $1,096,478.20 / $1,230,268.77
United
Facility/Professional
Professional
Modifier
Typical Low / Median / Typical High
$588,843.66 / $588,843.66 / $588,843.66